3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Prostatic Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Metastatic Castration-resistant Prostate Cancer
1
Lung Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Early Intervention, Educational
5
Radiotherapy
4
Psychiatric Rehabilitation
4
sargramostim
3
pembrolizumab
3
Trastuzumab
3
Methods
3
palbociclib
2
cediranib
2
Standard of Care
2
Specimen Handling
2
Mental Status and Dementia Tests
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
Interleukin-12 Subunit p35
2
Interferon-alpha
2
Fluorouracil
2
Fluorodeoxyglucose F18
2
Erlotinib Hydrochloride
2
Docetaxel
2
Counseling
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
tipifarnib
1
sapanisertib
1
relatlimab
1
pertuzumab
1
osimertinib
1
orantinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Radionuclide Imaging
×
Genitourinary
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled